Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
PAR PHARMACEUTICAL, INC. et al v. QUVA PHARMA, INC. et al
Case Number:
3:17-cv-06115
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
April 10, 2018
Par Pharma Blasts $102M Bond Ask In Trade Secrets Suit
Par Pharmaceutical Inc. shouldn't have to post a $102 million bond in its suit accusing QuVa Pharma Inc. of stealing trade secrets, as the amount is "egregiously excessive" and QuVa hasn't backed up its number with evidence, Par told a New Jersey federal court Monday.
-
March 02, 2018
Par Pharma Blocks Blood Pressure Drug Rival
Endo International unit Par Pharmaceutical Inc. won a bid for an injunction in a New Jersey suit against a competitor founded by two former employees who allegedly poached its personnel in an effort to steal trade secrets in order to reproduce a popular cardiopulmonary drug.
-
August 15, 2017
Par Pharma Claims Ex-Employees' New Co. Stole Secrets
Par Pharmaceuticals Inc. filed suit Monday in New Jersey federal court accusing a competitor founded by two former employees of poaching its personnel in an effort to steal trade secrets and rip off a popular cardiopulmonary drug.